Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer
- 1 January 2001
- Vol. 57 (1) , 122-126
- https://doi.org/10.1016/s0090-4295(00)00986-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PC‐SPES, a dietary supplement for the treatment of hormone‐refractory prostate cancerBJU International, 2000
- PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivoThe Prostate, 2000
- Effects of a phytotherapeutic agent, PC‐SPES, on prostate cancer: a preliminary investigation on human cell lines and patientsBJU International, 1999
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working GroupJournal of Clinical Oncology, 1999
- Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive diseaseUrology, 1999
- MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTSJournal of Urology, 1998
- Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerNew England Journal of Medicine, 1998
- A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerUrology, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945